Little dose, huge toxicity: profound hematological toxicity of intrathecal methotrexate.
Kose
Fatih
F
Abali
Huseyin
H
Sezer
Ahmet
A
Mertsoylu
Huseyin
H
Disel
Umut
U
Ozyilkan
Ozgur
O
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006403:Hematologic Tests; D006801:Humans; D007278:Injections, Spinal; D008224:Lymphoma, Follicular / Q000188:drug therapy / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects* / Q000494:pharmacology; D008875:Middle Aged; D009367:Neoplasm Staging; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone; D008727:Methotrexate